日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Safety and tolerability of tegoprubart in patients with amyotrophic lateral sclerosis: A Phase 2A clinical trial.

替戈普鲁巴特治疗肌萎缩侧索硬化症患者的安全性和耐受性：一项 2A 期临床试验

期刊:PLoS Medicine
影响因子:9.9
doi:10.1371/journal.pmed.1004469
Perrin Steven, Ladha Shafeeq, Maragakis Nicholas, Rivner Michael H, Katz Jonathan, Genge Angela, Olney Nicholas, Lange Dale, Heitzman Daragh, Bodkin Cynthia, Jawdat Omar, Goyal Namita A, Bornstein Jeffrey D, Mak Carmen, Appel Stanley H, Paganoni Sabrina
其它
发表日期：2024
文献求助 收藏

Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years

接受富马酸替诺福韦酯治疗长达 5 年的慢性乙型肝炎肝硬化患者的长期临床结局

期刊:Hepatology International
影响因子:6.1
doi:10.1007/s12072-015-9614-4
Buti, Maria; Fung, Scott; Gane, Edward; Afdhal, Nezam H; Flisiak, Robert; Gurel, Selim; Flaherty, John F; Martins, Eduardo B; Yee, Leland J; Dinh, Phillip; Bornstein, Jeffrey D; Mani Subramanian, G; Janssen, Harry L A; George, Jacob; Marcellin, Patrick
肝炎
肝硬化
发表日期：2015
文献求助 收藏

Nonoperative imaging techniques in suspected biliary tract obstruction

疑似胆道梗阻的非手术影像学检查

期刊:
影响因子:
doi:10.1080/13651820600746867
Tse, Frances; Barkun, Jeffrey S; Romagnuolo, Joseph; Friedman, Gad; Bornstein, Jeffrey D; Barkun, Alan N
发表日期：2006
文献求助 收藏